Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cellectis (CLLS) Shares Outstanding (Weighted Average) (2016 - 2025)

Cellectis has reported Shares Outstanding (Weighted Average) over the past 12 years, most recently at $5.9 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $5.9 million for Q4 2025, changed 0.24% from a year ago — trailing twelve months through Dec 2025 was $5.9 million (changed 0.24% YoY), and the annual figure for FY2025 was $5.9 million, changed 0.24%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $5.9 million at Cellectis, roughly flat from $5.9 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for CLLS hit a ceiling of $71.8 million in Q4 2023 and a floor of $3.5 million in Q2 2023.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $5.9 million (2025), compared with a mean of $26.0 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): skyrocketed 57.09% in 2023 and later tumbled 91.79% in 2024.
  • Cellectis' Shares Outstanding (Weighted Average) stood at $45.5 million in 2021, then increased by 0.42% to $45.7 million in 2022, then skyrocketed by 57.09% to $71.8 million in 2023, then tumbled by 91.79% to $5.9 million in 2024, then increased by 0.24% to $5.9 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $5.9 million (Q4 2025), $5.9 million (Q4 2024), and $71.8 million (Q4 2023) per Business Quant data.